Literature DB >> 11758809

Distribution of microsomal epoxide hydrolase in humans: an immunohistochemical study in normal tissues, and benign and malignant tumours.

J K Coller1, P Fritz, U M Zanger, I Siegle, M Eichelbaum, H K Kroemer, T E Mürdter.   

Abstract

Microsomal epoxide hydrolase is a biotransformation enzyme which is involved in the hydrolysis of various epoxides and epoxide intermediates. In the present study, its distribution was investigated in both normal human tissues and human tumours of different histogenetic origin using immunohistochemical techniques. In normal tissue, epithelial cells were more often and more intensely immunostained than mesenchymal cells. The main epithelial cell types expressing microsomal epoxide hydrolase were hepatocytes, acinus cells of the pancreas, and cells of salivary and adrenal glands. Immunostained cells of mesenchymal origin included monocytes, fibrocytes, fibroblasts, vessel endothelium, muscle cells, and cells of the reproductive system. Three patterns of expression were observed in tumour tissues: (1) moderate or strong in hepatocellular carcinomas, tumours of the adrenal gland, and theca-fibromas of the ovary; (2) inhomogeneous staining pattern of variable intensity in breast cancer, lung cancer, colorectal carcinomas, carcinoid tumours, and some tumours of mesenchymal origin; and (3) no expression in malignant melanomas, malignant lymphomas, and renal carcinomas. These data indicate that microsomal epoxide hydrolase expression is not restricted to tissue of any particular histogenetic origin. Nonetheless, immunohistochemical identification of microsomal epoxide hydrolase may be helpful in some well-defined histological settings, for example, confirmation of hepatocellular carcinoma.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11758809     DOI: 10.1023/a:1012414806166

Source DB:  PubMed          Journal:  Histochem J        ISSN: 0018-2214


  14 in total

1.  Monoclonal antibodies reveal multiple forms of expression of human microsomal epoxide hydrolase.

Authors:  Hongying Duan; Akira Takagi; Hidekazu Kayano; Isamu Koyama; Christophe Morisseau; Bruce D Hammock; Toshitaka Akatsuka
Journal:  Toxicol Appl Pharmacol       Date:  2012-01-28       Impact factor: 4.219

2.  In Vitro Metabolism of Oprozomib, an Oral Proteasome Inhibitor: Role of Epoxide Hydrolases and Cytochrome P450s.

Authors:  Zhican Wang; Ying Fang; Juli Teague; Hansen Wong; Christophe Morisseau; Bruce D Hammock; Dan A Rock; Zhengping Wang
Journal:  Drug Metab Dispos       Date:  2017-04-20       Impact factor: 3.922

3.  Microsomal epoxide hydrolase expression in the endometrial uterine corpus is regulated by progesterone during the menstrual cycle.

Authors:  Simone L Popp; Ina S Abele; Miriam B Buck; Matthias B Stope; Leen J Blok; Payman Hanifi-Moghaddam; Curt W Burger; Peter Fritz; Cornelius Knabbe
Journal:  J Mol Histol       Date:  2010-04-13       Impact factor: 2.611

4.  Functional analysis of human microsomal epoxide hydrolase genetic variants.

Authors:  Vinayak P Hosagrahara; Allan E Rettie; Christopher Hassett; Curtis J Omiecinski
Journal:  Chem Biol Interact       Date:  2004-11-20       Impact factor: 5.192

Review 5.  Small Airway Susceptibility to Chemical and Particle Injury.

Authors:  Leonie Francina Hendrina Fransen; Martin Oliver Leonard
Journal:  Respiration       Date:  2021-10-14       Impact factor: 3.966

Review 6.  Microsomal epoxide hydrolase 1 (EPHX1): Gene, structure, function, and role in human disease.

Authors:  Radka Václavíková; David J Hughes; Pavel Souček
Journal:  Gene       Date:  2015-07-26       Impact factor: 3.688

7.  Expression of a novel mRNA transcript for human microsomal epoxide hydrolase (EPHX1) is regulated by short open reading frames within its 5'-untranslated region.

Authors:  Hong Loan Nguyen; Xi Yang; Curtis J Omiecinski
Journal:  RNA       Date:  2013-04-05       Impact factor: 4.942

8.  Effects of deletion of the transcription factor Nrf2 and benzo [a]pyrene treatment on ovarian follicles and ovarian surface epithelial cells in mice.

Authors:  Jinhwan Lim; Laura Ortiz; Brooke N Nakamura; Yvonne D Hoang; Jesus Banuelos; Victoria N Flores; Jefferson Y Chan; Ulrike Luderer
Journal:  Reprod Toxicol       Date:  2015-08-03       Impact factor: 3.143

9.  EPHX1 mutations cause a lipoatrophic diabetes syndrome due to impaired epoxide hydrolysis and increased cellular senescence.

Authors:  Jeremie Gautheron; Christophe Morisseau; Wendy K Chung; Jamila Zammouri; Martine Auclair; Genevieve Baujat; Emilie Capel; Celia Moulin; Yuxin Wang; Jun Yang; Bruce D Hammock; Barbara Cerame; Franck Phan; Bruno Fève; Corinne Vigouroux; Fabrizio Andreelli; Isabelle Jeru
Journal:  Elife       Date:  2021-08-03       Impact factor: 8.140

10.  Phase I metabolic genes and risk of lung cancer: multiple polymorphisms and mRNA expression.

Authors:  Melissa Rotunno; Kai Yu; Jay H Lubin; Dario Consonni; Angela C Pesatori; Alisa M Goldstein; Lynn R Goldin; Sholom Wacholder; Robert Welch; Laurie Burdette; Stephen J Chanock; Pier Alberto Bertazzi; Margaret A Tucker; Neil E Caporaso; Nilanjan Chatterjee; Andrew W Bergen; Maria Teresa Landi
Journal:  PLoS One       Date:  2009-05-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.